- Home
- KO vs JNJ Comparison
KO vs JNJ Comparison
Compare KO & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KO
- JNJ
- Stock Information
- Founded
- KO 1886
- JNJ 1886
- Country
- KO United States
- JNJ United States
- Employees
- KO N/A
- JNJ N/A
- Industry
- KO Beverages (Production/Distribution)
- JNJ Biotechnology: Pharmaceutical Preparations
- Sector
- KO Consumer Staples
- JNJ Health Care
- Exchange
- KO Nasdaq
- JNJ Nasdaq
- Market Cap
- KO 309.3B
- JNJ 370.9B
- IPO Year
- KO 1919
- JNJ 1944
- Fundamental
- Price
- KO $72.09
- JNJ $154.96
- Analyst Decision
- KO Strong Buy
- JNJ Buy
- Analyst Count
- KO 16
- JNJ 16
- Target Price
- KO $75.63
- JNJ $169.33
- AVG Volume (30 Days)
- KO 14.4M
- JNJ 8.3M
- Earning Date
- KO 07-22-2025
- JNJ 07-16-2025
- Dividend Yield
- KO 2.83%
- JNJ 3.35%
- EPS Growth
- KO 0.01
- JNJ N/A
- EPS
- KO 2.49
- JNJ 8.98
- Revenue
- KO $46,890,000,000.00
- JNJ $89,331,000,000.00
- Revenue This Year
- KO $5.32
- JNJ $3.87
- Revenue Next Year
- KO $5.31
- JNJ $4.15
- P/E Ratio
- KO $28.96
- JNJ $17.27
- Revenue Growth
- KO 1.77
- JNJ 4.30
- 52 Week Low
- KO $60.62
- JNJ $140.68
- 52 Week High
- KO $74.38
- JNJ $169.99
- Technical
- Relative Strength Index (RSI)
- KO 54.70
- JNJ 53.52
- Support Level
- KO $70.46
- JNJ $151.56
- Resistance Level
- KO $72.22
- JNJ $154.04
- Average True Range (ATR)
- KO 0.99
- JNJ 2.29
- MACD
- KO 0.06
- JNJ 0.41
- Stochastic Oscillator
- KO 90.23
- JNJ 92.18
About KO Coca-Cola Company (The)
Founded in 1886, Atlanta-headquartered Coca-Cola is the world's largest nonalcoholic beverage company, with a strong portfolio of 200 brands covering key categories including carbonated soft drinks, water, sports, energy, juice, and coffee. Together with bottlers and distribution partners, the company sells finished beverage products bearing Coca-Cola and licensed brands through retailers and food-service locations in more than 200 countries and regions globally. Coca-Cola generates around two thirds of its total revenue overseas, with a significant portion from emerging economies in Latin America and Asia-Pacific.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.